Literature DB >> 20470942

Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer: a meta-analysis.

Xingli Dong1, Jianing Wu, Peng Liang, Jihong Li, Lijie Yuan, Xinghan Liu.   

Abstract

BACKGROUND AND AIMS: Case/control studies that investigated the association between gastric cancer and the MTHFR C677T and A1298C polymorphisms so far have provided controversial results. To clarify the effect of MTHFR polymorphisms on the risk of gastric cancer, a meta-analysis was performed.
METHODS: We performed a computerized search of the PubMed database for relevant reports before September 2009. No language restrictions were added. The associated literature was acquired through a deliberate retrieval strategy and selected based on the established inclusion criteria for publications.
RESULTS: The studies provided 4070/6462 cases/controls for C677T and 1923/3561 cases/controls for A1298C. There was significant heterogeneity (p = 0.015, I(2) = 44.0%) among the 22 studies, and the RE model showed that the C677T allele T was associated with a 17.3% increased risk of gastric cancer compared with the allele C (RE OR = 1.173 [1.051-1.274]). Results from the subgroup analysis showed an increased risk in Asians (fixed-effect, FE OR 1.277 [1.179-1.382]), but not in Caucasians (random-effect, RE OR 1.194 [0.866-1.646]). The contrast of homozygotes (TT vs. CC) produced significant results in Asians (FE OR 1.611 [1.366-1.901]), whereas, in Caucasians, it was not significant (RE OR 1.385 [0.754-2.544]). In regard to the A1298C polymorphism, there was no heterogeneity among the 11 studies comparing the C vs. the A allele (p = 0.352, I(2) = 9.7%), but no significant association was detected.
CONCLUSIONS: The evidence from our meta-analysis supports that TT genotype of MTHFR C677T polymorphism contributes to susceptibility to gastric cancer, but no significant association was detected for CC genotype of MTHFR A1298C. Copyright 2010 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20470942     DOI: 10.1016/j.arcmed.2010.01.001

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  15 in total

Review 1.  Genetics and gastric cancer susceptibility.

Authors:  Yan Lu; Fang Lu; Sha Zeng; Suqing Sun; Li Lu; Lifeng Liu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Quantitative assessment of the association between MTHFR C677T polymorphism and colorectal cancer risk in East Asians.

Authors:  Shan Zhong; Jia-He Yang; Kai Liu; B H Jiao; Zhi-Jie Chang
Journal:  Tumour Biol       Date:  2012-08-15

3.  Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men.

Authors:  Mohammad Reza Safarinejad; Nayyer Shafiei; Shiva Safarinejad
Journal:  Med Oncol       Date:  2010-10-29       Impact factor: 3.064

4.  MTHFR C677T polymorphism contributes to the risk for gastric cancer.

Authors:  Shushan Yan; Donghua Xu; Pingping Wang; Ping Wang; Chengcheng Liu; Changjiang Hua; Tao Jiang; Bin Zhang; Zengcai Li; Lei Lu; Xianzhong Liu; Bingji Wang; Donghua Zhang; Rongsheng Zhang; Shaoheng He; Beicheng Sun; Xuan Wang
Journal:  Tumour Biol       Date:  2014-03

5.  MTHFR C677T and A1298C polymorphisms and cervical carcinoma susceptibility: meta-analyses based on 4,421 individuals.

Authors:  Wen-Lei Zhuo; Liang Zhang; Jun-Jun Ling; Yi Zhu; Zheng-Tang Chen
Journal:  Mol Biol Rep       Date:  2012-06-19       Impact factor: 2.316

6.  No association of the MTHFR gene A1298C polymorphism with the risk of prostate cancer: A meta-analysis.

Authors:  Dawei Li; Tian Tian; Chunhui Guo; Juchao Ren; Lei Yan; Hainan Liu; Zhonghua Xu
Journal:  Exp Ther Med       Date:  2012-01-04       Impact factor: 2.447

Review 7.  Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility.

Authors:  Lei-Zhou Xia; Yi Liu; Xiao-Zhou Xu; Peng-Cheng Jiang; Gui Ma; Xue-Feng Bu; Yong-Jun Zhang; Feng Yu; Ke-Sen Xu; Hua Li
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

8.  The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.

Authors:  Long Lv; Ping Wang; Beicheng Sun; Gong Chen
Journal:  Tumour Biol       Date:  2013-07-30

9.  Polymorphism of TS 3'-UTR predicts survival of Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.

Authors:  J Gao; Q He; D Hua; Y Mao; Y Li; L Shen
Journal:  Clin Transl Oncol       Date:  2012-12-21       Impact factor: 3.405

10.  Impact of methylenetetrahydrofolate reductase C677T polymorphism on the risk of gastric cancer and its interaction with Helicobacter pylori infection.

Authors:  Samaneh Saberi; Kazem Zendehdel; Sahar Jahangiri; Yeganeh Talebkhan; Afshin Abdirad; Nazanin Mohajerani; Maryam Bababeik; Najmeh Karami; Maryam Esmaili; Akbar Oghalaie; Parisa Hassanpour; Neda Amini; Mohammad Ali Mohagheghi; Mahmoud Eshagh Hossieni; Marjan Mohammadi
Journal:  Iran Biomed J       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.